Systems and methods for characterizing a patient's propensity for a neurological event and for communicating with a pharmacological agent dispenser
First Claim
1. A method for controlling administration of a pharmacological agent for treating epilepsy, the method comprising processing one or more signals from a patient to characterize a patient'"'"'s propensity for a future seizure, and based upon measuring an increased propensity for the future seizure, allowing the patient to access the pharmacological agent from a dispenser.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides systems and methods for managing intake of a pharmacological agent. In one method of the present invention, the systems and methods are for controlling intake of an anti-epileptic drug. In such embodiments, one or more signals from a patient are processed to predict an onset of a seizure. Upon the prediction of the seizure, the patient is allowed to access the pharmacological agent in a pharmacological agent dispenser.
-
Citations
51 Claims
- 1. A method for controlling administration of a pharmacological agent for treating epilepsy, the method comprising processing one or more signals from a patient to characterize a patient'"'"'s propensity for a future seizure, and based upon measuring an increased propensity for the future seizure, allowing the patient to access the pharmacological agent from a dispenser.
-
25. A method for controlling administration of an anti-epileptic drug, the method comprising:
-
measuring one or more signals from a patient;
extracting one or more features from the one or more signals;
classifying at least some of the extracted features to characterize the patient'"'"'s propensity for a future seizure; and
based upon the patient'"'"'s increased propensity for the future seizure, transmitting a signal to a drug dispenser that enables the patient to dispense the pharmacological agent from the pharmacological agent dispenser. - View Dependent Claims (26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)
-
-
37. A method for controlling administration of a pharmacological agent for managing a predicted seizure, the method comprising:
-
characterizing a patient'"'"'s neural state to estimate a patient'"'"'s propensity for a future seizure;
wherein if the patient'"'"'s neural state is indicative of an increased propensity for a future seizure;
processing the neural state to determine an appropriate acute pharmacological treatment for managing the future seizure;
providing an output to the patient; and
transmitting a signal to a pharmacological agent dispenser that permits the use of the pharmacological agent dispenser and administration of the appropriate pharmacological treatment to the patient. - View Dependent Claims (38, 39, 40, 41)
-
-
42. A method of communicating with a drug delivery assembly that is external to a patient'"'"'s body, the method comprising:
-
measuring one or more physiological parameters with one or more implanted sensors;
transcutaneously transmitting one or more signals from the implanted sensors that are reflective of the measured physiological parameters to a predictive algorithm that is external to the patient'"'"'s body; and
analyzing the one or more signals with the predictive algorithm to measure a patient'"'"'s neural state that is indicative of a patient'"'"'s propensity for an onset of a future seizure, wherein if the patient'"'"'s neural state indicates an increased propensity for the onset of a future seizure, transmitting a signal to a manually activatable drug delivery device that is external to the patient'"'"'s body.
-
-
43. A method of predicting an onset of a seizure, the method comprising:
-
monitoring one or more signals from the patient;
extracting features from the one or more signals in a device that is implanted in the patient'"'"'s body;
transmitting at least some of the extracted features transcutaneously to a device that is external to the patient'"'"'s body; and
classifying at least some of the transmitted features to characterize the patient'"'"'s propensity for a future seizure in the device that is external to the patient'"'"'s body. - View Dependent Claims (44, 45, 46, 47, 48, 49, 50, 51)
-
Specification